How have IMUN shares performed in 2024?

Immune Therapeutics' stock was trading at $0.0930 at the beginning of 2024. Since then, IMUN stock has increased by 0.0% and is now trading at $0.0930. View the best growth stocks for 2024 here .

What other stocks do shareholders of Immune Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immune Therapeutics investors own include Northwest Biotherapeutics (NWBO) , Alexion Pharmaceuticals (ALXN) , AK Steel (AKS) , Galiano Gold (AKG) , Agritek (AGTK) , Agenus (AGEN) , Affymetrix (AFFX) , Advanced Disposal Services (ADSW) , Adamis Pharmaceuticals (ADMP) and Analog Devices (ADI) .

How do I buy shares of Immune Therapeutics?

Shares of IMUN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:IMUN

Immune Therapeutics (IMUN) Stock Price, News & Analysis

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Free IMUN Stock Alerts

$0.09

0.00 (0.00%)

(As of 10/19/2023)

Compare

Today's Range: $0.09
▼
$0.09
50-Day Range: $0.09
▼
$0.09
52-Week Range: $0.07
▼
$1.30

Volume: 12 shs
Average Volume: 15,246 shs
Market Capitalization: $7.78 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings

Get Immune Therapeutics alerts:

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Immune Therapeutics Stock (OTCMKTS:IMUN)

Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. is based in Winter Park, Florida.

IMUN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IMUN Stock News Headlines

April 11, 2024 | msn.com

These Stocks Are Moving the Most Today: Alpine Immune, CarMax, Robinhood, Fastenal, Nike, Constellation Brands, and More

April 8, 2024 | markets.businessinsider.com

Buy Rating Affirmed for Alpine Immune Sciences Amid Positive Clinical Trial Results

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 8, 2024 | msn.com

Rogue immune cell that can cause poor antibody responses in chronic viral infections discovered

April 5, 2024 | finance.yahoo.com

Immunis Discusses with Experts Why the Immune System is the Key to Human Healthspan

March 31, 2024 | msn.com

Researchers identify new way to inhibit immune cells that drive allergic asthma

March 29, 2024 | finance.yahoo.com

BIRM Is Using Nature to Balance the Immune System

March 25, 2024 | usnews.com

Russian Security Failure? Kremlin Says No Country Is Immune to Terrorism

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 21, 2024 | msn.com

Scientists shed light on key immune regulators involved in Alzheimer’s and other disorders of lipid-rich tissues

March 19, 2024 | msn.com

Empty 'backpacks' attached to neutrophils activate the immune system against cancer

March 19, 2024 | msn.com

New drug candidates could 'unmask' HIV-infected cells that evade the immune system

March 18, 2024 | msn.com

New Medical Breakthrough: Innovative Application of Immune Protein

March 11, 2024 | msn.com

Revolutionary Breakthrough: Unraveling the Role of an Immune Protein with Therapeutic Potential

March 7, 2024 | msn.com

A Key to Immunity Unlocked: How a Novel Discovery of an Immune Protein Opens Up New Possibilities for Healing

March 4, 2024 | msn.com

Immune Protein’s Novel Use: A Leap Forward in Medical Treatment

March 4, 2024 | msn.com

Immune Protein’s Newly Found Role May Pave Way for Groundbreaking Medical Advances

February 26, 2024 | msn.com

A groundbreaking discovery: the function of an immune protein, opening up new possibilities for revolutionary therapies

February 22, 2024 | msn.com

Immune cell receptor provides promising immunotherapy target

February 22, 2024 | msn.com

How an immune protein works: a breakthrough finding with potential for radical therapies

February 19, 2024 | msn.com

Scientists Have Made A Groundbreaking Discovery – A New Application For An Immune Protein That Could Revolutionize Treatments

February 19, 2024 | msn.com

Researchers Discovered A New Function For An Immune Protein That May Result In Revolutionary Treatments

February 16, 2024 | finance.yahoo.com

Smart Immune appoints key new members to its Board of Directors

February 14, 2024 | msn.com

Alzheimer's Linked to Epigenetic Changes in Immune Cells Outside The Brain

February 13, 2024 | msn.com

Scientists Have Made A Groundbreaking Discovery By Finding A New Purpose For An Immune Protein， which Could Lead To Groundbreaking Treatments

February 8, 2024 | msn.com

Scientists have made a groundbreaking discovery about the function of an immune protein, opening up new possibilities for revolutionary therapies

February 6, 2024 | msn.com

Trump Is Not Immune From Prosecution in His 2020 Election Interference Case, US Appeals Court Says

See More Headlines

Receive IMUN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immune Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:IMUN
CUSIP: N/A
CIK: 1559356
Web: www.immunetherapeutics.com
Phone: (888) 613-8802
Fax: N/A
Employees: 2
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-3,540,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -544.75%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.03) per share
Price / Book: -3.10

Miscellaneous

Outstanding Shares: 83,660,000
Free Float: 41,335,000
Market Cap: $7.78 million
Optionable: Not Optionable
Beta: 0.46

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Ms. Kelly O'Brien Wilson (Age 51)
Interim CEO, COO & Pres
Comp: $53.83k
Ms. Noreen M. Griffin (Age 70)
Exec. VP of Bus. Devel. & CEO
Mr. Glen A. Farmer M.B.A. (Age 54)
Chief Financial Officer
Ms. Cynthia Douglas (Age 50)
Company Sec.
Dr. Joseph M. Fortunak (Age 68)
VP of Global R&D and Chemical Devel.

Key Competitors

View All Competitors

IMUN Stock Analysis - Frequently Asked Questions

How have IMUN shares performed in 2024?: Immune Therapeutics' stock was trading at $0.0930 at the beginning of 2024. Since then, IMUN stock has increased by 0.0% and is now trading at $0.0930.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Immune Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Immune Therapeutics investors own include Northwest Biotherapeutics (NWBO), Alexion Pharmaceuticals (ALXN), AK Steel (AKS), Galiano Gold (AKG), Agritek (AGTK), Agenus (AGEN), Affymetrix (AFFX), Advanced Disposal Services (ADSW), Adamis Pharmaceuticals (ADMP) and Analog Devices (ADI).
How do I buy shares of Immune Therapeutics?: Shares of IMUN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:IMUN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Immune Therapeutics (IMUN) Stock Price, News & Analysis

About Immune Therapeutics Stock (OTCMKTS:IMUN)

IMUN Stock Price History

IMUN Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

IMUN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info